CD40 ligand gene and Kawasaki disease

被引:44
|
作者
Onouchi, Y
Onoue, S
Tamari, M
Wakui, K
Fukushima, Y
Yashiro, M
Nakamura, Y
Yanagawa, H
Kishi, F
Ouchi, K
Terai, M
Hamamoto, K
Kudo, F
Aotsuka, H
Sato, Y
Nariai, A
Kaburagi, Y
Miura, M
Saji, T
Kawasaki, T
Nakamura, Y
Hata, A
机构
[1] RIKEN, SNP Res Ctr, Lab Gastrointestinal Dis, Kanagawa 2300045, Japan
[2] RIKEN, SNP Res Ctr, Lab Genet Allerg Dis, Kanagawa 2300045, Japan
[3] Shinshu Univ, Sch Med, Dept Prevent Med, Matsumoto, Nagano, Japan
[4] Jichi Med Sch, Dept Publ Hlth, Minami Kawachi, Tochigi, Japan
[5] Saitama Prefectural Univ, Urawa, Saitama, Japan
[6] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Dev Med, Div Mol Genet, Kagoshima 890, Japan
[7] Kawasaki Med Sch, Dept Pediat, Kawasaki, Kanagawa, Japan
[8] Chiba Univ, Grad Sch Med, Dept Pediat, Chiba, Japan
[9] Fukuoka Univ, Sch Med, Dept Pediat, Fukuoka, Japan
[10] Chiba Childrens Hosp, Dept Otorhinolaryngol, Chiba, Japan
[11] Chiba Childrens Hosp, Dept Cardiol, Chiba, Japan
[12] Fuji Heavy Ind Co Ltd, Hlth Insurance Soc Gen Ota Hosp, Dept Pediat, Fuji, Shizuoka, Japan
[13] Yokohama Minami Kyosai Hosp, Dept Pediat, Yokohama, Kanagawa, Japan
[14] Seirei Yokohama Hosp, Dept Pediat, Yokohama, Kanagawa, Japan
[15] Keio Univ, Sch Med, Dept Pediat, Tokyo 108, Japan
[16] Toho Univ, Sch Med, Dept Pediat 1, Funabashi, Chiba, Japan
[17] Japan Kawasaki Dis Res Ctr, Kawasaki, Kanagawa, Japan
[18] Univ Tokyo, Inst Med Sci, Human Genome Ctr, Mol Med Lab, Tokyo, Japan
[19] Chiba Univ, Grad Sch Med, Dept Publ Hlth, Chiba, Japan
关键词
Kawasaki disease; coronary artery lesion; CD40L; SNPs;
D O I
10.1038/sj.ejhg.5201266
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Kawasaki disease (KD) is an acute systemic vasculitis syndrome of infants and young children. Although its etiology is largely unknown, epidemiological findings suggest that genetic factors play a role in the pathogenesis of KD. To identify genetic factors, affected sib-pair analysis has been performed. One of the identified peaks was located on the Xq26 region. A recent report of elevated expression of CD40 ligand (CD40L), which maps to Xq26, during the acute-phase KD, and its relationship to the development of coronary artery lesions (CAL) prompted us to screen for polymorphism of CD40L and to study the association of the gene to KD. A newly identified SNP in intron 4 (IVS4+121 A>G) is marginally over-represented in KD patients as compared to controls (109/602, 18.1 vs 111/737, 15.1%). When male KD patients with CAL were analyzed as a patient group, the SNP was significantly more frequent than in controls (15/58, 25.9%, vs 111/737, 15.1%, OR 2.0, 95% CI 1.07-3.66; P=0.030). Interestingly, this variation was extremely rare in a control Caucasian population (1/145, 0.7%). Our results suggest a role of CD40L in the pathogenesis of CAL and might explain the excess of males affected with KD.
引用
收藏
页码:1062 / 1068
页数:7
相关论文
共 50 条
  • [41] THE BIOLOGY OF THE HUMAN LIGAND FOR CD40
    SPRIGGS, MK
    FANSLOW, WC
    ARMITAGE, RJ
    BELMONT, J
    JOURNAL OF CLINICAL IMMUNOLOGY, 1993, 13 (06) : 373 - 380
  • [42] CD40 and its ligand in atherosclerosis
    Lutgens, Esther
    Lievens, Dirk
    Beckers, Linda
    Donners, Marjo
    Daemen, Mat
    TRENDS IN CARDIOVASCULAR MEDICINE, 2007, 17 (04) : 118 - 123
  • [43] THE INFLUENCE OF CD40/CD40 LIGAND ON THE PROGNOSIS OF CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    Patiroglu, T.
    Unal, E.
    Karakukcu, M.
    Mutlu, F. T.
    Ozdemir, M. A.
    HAEMATOLOGICA, 2012, 97 : 493 - 494
  • [44] Association between CD40 polymorphisms and systemic lupus erythematosus and correlation between soluble CD40 and CD40 ligand levels in the disease: a meta-analysis
    Bae, S. -C
    Lee, Y. H.
    LUPUS, 2019, 28 (12) : 1452 - 1459
  • [45] Systemic upregulation of CD40 and CD40 ligand mRNA expression in multiple sclerosis
    Huang, WX
    Huang, P
    Hillert, J
    MULTIPLE SCLEROSIS, 2000, 6 (02): : 61 - 65
  • [46] Regulation of CD40 and CD40 ligand by the AT-hook transcription factor AKNA
    Aisha Siddiqa
    Jennifer C. Sims-Mourtada
    Liliana Guzman-Rojas
    Roberto Rangel
    Christiane Guret
    Vicente Madrid-Marina
    Yan Sun
    Hector Martinez-Valdez
    Nature, 2001, 410 : 383 - 387
  • [47] Platelet expression of CD40 and CD40 ligand during persistent atrial fibrillation
    Hammwöhner, M
    Ittenson, A
    Dierkes, J
    Klein, HU
    Goette, A
    CIRCULATION, 2004, 110 (17) : 742 - 742
  • [48] Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis
    María Teruel
    Carmen P Simeon
    Jasper Broen
    Madelon C Vonk
    Patricia Carreira
    Maria Teresa Camps
    Rosa García-Portales
    Esmeralda Delgado-Frías
    Maria Gallego
    Gerard Espinosa
    Lorenzo Beretta
    Paolo Airó
    Claudio Lunardi
    Gabriela Riemekasten
    Torsten Witte
    Thomas Krieg
    Alexander Kreuter
    Jörg HW Distler
    Nicolas Hunzelmann
    Bobby P Koeleman
    Alexandre E Voskuyl
    Annemie J Schuerwegh
    Miguel Ángel González-Gay
    Timothy RDJ Radstake
    Javier Martin
    Arthritis Research & Therapy, 14
  • [49] Coexpression of CD40 and CD40 ligand in B-cell lymphoma cells
    Clodi, K
    Asgary, Z
    Zhao, SR
    Kliche, KO
    Cabanillas, F
    Andreeff, M
    Youns, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (01) : 270 - 275
  • [50] Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis
    Teruel, Maria
    Simeon, Carmen P.
    Broen, Jasper
    Vonk, Madelon C.
    Carreira, Patricia
    Teresa Camps, Maria
    Garcia-Portales, Rosa
    Delgado-Frias, Esmeralda
    Gallego, Maria
    Espinosa, Gerard
    Beretta, Lorenzo
    Airo, Paolo
    Lunardi, Claudio
    Riemekasten, Gabriela
    Witte, Torsten
    Krieg, Thomas
    Kreuter, Alexander
    Distler, Joerg H. W.
    Hunzelmann, Nicolas
    Koeleman, Bobby P.
    Voskuyl, Alexandre E.
    Schuerwegh, Annemie J.
    Angel Gonzalez-Gay, Miguel
    Radstake, Timothy R. D. J.
    Martin, Javier
    ARTHRITIS RESEARCH & THERAPY, 2012, 14 (03)